List view / Grid view

David Brennan

 

news

Amgen and AstraZeneca announce collaboration

Collaboration comprises five monoclonal antibodies brodalumab (AMG 827) Phase 3…

2 April 2012 | By Amgen

Collaboration comprises five monoclonal antibodies brodalumab (AMG 827) Phase 3 trial planned in 2012...

news

AstraZeneca to cut a further 7,300 jobs

AstraZeneca has announced new restructuring initiatives designed to improve productivity…

2 February 2012 | By AstraZeneca

AstraZeneca has announced new restructuring initiatives designed to improve productivity and strengthen the company’s capabilities...

news

CRESTOR Patent Upheld By US Court

AstraZeneca announced today that Judge Joseph Farnan, Jr., US District…

30 June 2010 | By AstraZeneca

AstraZeneca announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 – the ‘314 patent) is valid and enforceable...

news

AstraZeneca and MMV Join Efforts in the Fight Against Malaria

AstraZeneca and Medicines for Malaria Venture (MMV) today announced a…

28 June 2010 | By AstraZeneca

AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria...